INFECT-NL is a Dutch national collaboration focussing on accelerating

the development of novel products to combat infectious diseases

worldwide. Building on the leading expertise of the Dutch academia,

INFECT-NL aims to innovate early stage clinical research development,

with a focus on controlled human infection models.

Associate Professor dr. Amanda Foks leads her own research group ‘Aging and Immunity’ at the Division of BioTherapeutics at the Leiden Academic Centre for Drug Research (LACDR, Leiden University). Her research team is dedicated to understand the complex mechanisms underlying the effects of aging on immune cells, and its contributions to atherosclerosis, with the ultimate goal of developing innovative strategies to combat cardiovascular disease.

CHDR is an independent institute specialising in innovative early-stage clinical drug research.